Oxaliplatin HAIC (130 mg/m²)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Oxaliplatin HAIC (130 mg/m²), covering 2021-01-13 to 2021-01-13. Get the full timeline:
Most recent: Clinical Trial Update: Sorafenib or Lenvatinib Plus HAIC of 130 mg/m² Oxaliplatin, and 5-fu vs Sorafenib or Lenvatinib Plus HAIC of 85mg/m² Oxaliplatin, and 5-fu for Unresectable Advanced HCC: a Randomised Phase 3 Trial [Phase 3]